Related Experiment Video
Updated: Apr 26, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
[Chronic kidney disease and sudden death]
Insights
Sudden cardiac death (SCD) is a leading cause of mortality in chronic kidney disease (CKD) patients undergoing hemodialysis. This review explores SCD
Area of Science:
- Nephrology
- Cardiology
- Public Health
Context:
- Cardiovascular disease (CVD) is the primary cause of death in chronic kidney disease (CKD) patients, responsible for 43% of mortality in hemodialysis (HD) patients.
- Sudden cardiac death (SCD) is a significant and life-threatening clinical syndrome in end-stage renal disease (ESRD).
- CKD patients on HD exhibit numerous non-traditional CVD risk factors, including left ventricular hypertrophy, coronary artery disease, and electrolyte imbalances.
Purpose:
- To review the epidemiology and pathophysiology of SCD in CKD patients.
- To outline current prevention and treatment guidelines for SCD in this population.
Summary:
- Cardiovascular disease (CVD) is the leading cause of death in chronic kidney disease (CKD) patients, particularly those on hemodialysis (HD).
- Sudden cardiac death (SCD) is a frequent and dangerous complication in end-stage renal disease (ESRD) patients.
- Non-traditional cardiovascular risk factors prevalent in HD patients contribute to SCD, including left ventricular hypertrophy, coronary artery disease, rapid electrolyte shifts, QT dispersion, sympathetic hyperactivity, and hyperphosphatemia.
Impact:
- Provides a comprehensive overview of SCD in CKD patients.
- Highlights key risk factors and pathophysiological mechanisms.
- Offers guidance on prevention and treatment strategies to reduce SCD mortality in CKD patients.
Abstract:
Cardiovascular disease represents the major cause of death in chronic kidney disease patients accounting for about 43% of all mortality causes among hemodialysis patients. Sudden cardiac death (SCD) is one of the most frequent and dangerous clinical syndrome occurring in end stage renal disease (ESRD) patients. Hemodialysis patients present a great number of non traditional risk factors for cardiovascular disease such as left ventricular hypertrophy, coronary artery disease, rapid electrolyte shifts, QT dispersion, sympathetic hyperactivity and hyperphosphatemia. The aim of the following review is to summarize epidemiological aspects and pathophysiological pathways of SCD in CKD patients, defining prevention and treatment guidelines.
More Related Videos
Related Concept Videos
Chronic Kidney Disease I: Introduction
Acute Kidney Injury I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease III: Interprofessional Care

